Sensor Shows Promise to Help Diagnose, Treat Crohn’s, UC, Study Says

Sensor Shows Promise to Help Diagnose, Treat Crohn’s, UC, Study Says
A new device could help doctors distinguish between two subtypes of inflammatory bowel disease (IBD) and prove a powerful tool in evaluating patients’ response to treatment, according to a recent study. “Clinical Characterization Of In Vivo Inflammatory Bowel Disease With Raman Spectroscopy” was published in the journal Biomedical Optics Express. IBD includes ulcerative colitis (UC), which affects the colon, and Crohn's disease, which can affect any organ in the gastrointestinal tract. The diseases have similar symptoms, including severe diarrhea, pain, fatigue and weight loss. Both manifest through similar symptoms, such as severe diarrhea, pain, fatigue and weight loss, but no single treatment has been proven effective for all patients. Existing methods for diagnosing and treating UC and Crohn’s disease are inefficient, the researchers said, because they rely on a trial-and-error approach. "With current methods, ultimately the diagnosis is dependent on how the patient responds to therapy over time, and you often don't know the diagnosis until it's been a few years," Anita Mahadevan-Jansen, senior author of the paper, said in a news release. Furthermore, most tools used during diagnosis and follow-up detect symptoms but are not able to reveal what caused the disease. As a result, many patients receive an incomplete diagnosis or are re-diagnosed based on their response to a therapy. To resolve that issue, Mahadevan-J
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *